PHQ-2 Depression Pre-Screener

The Patient Health Questionnaire-2 (PHQ-2) is a brief, two-item tool that screens for depressed mood and loss of interest over the past two weeks. Clinicians use it as a first-step screen to decide whether a fuller assessment for depression is warranted. Each item is scored 0 to 3, for a total of 0 to 6.

Why healthcare providers use the PHQ-2

Fast to complete. Two questions take under a minute, so the screen fits into routine visits without slowing intake.
Evidence-based screen. Validated against structured diagnostic interviews, it reliably flags patients who need a closer look for depression.
Front-line triage. A positive result points staff toward a fuller assessment such as the PHQ-9, focusing clinician time where it matters.
Consistent measurement. Standardized wording and a fixed scale let you compare results across patients and across visits.

Which settings use the PHQ-2?

Primary care. Used for routine depression screening during annual exams and chronic-care visits.
Behavioral health. Serves as a quick intake screen before a more detailed diagnostic evaluation.
Integrated and specialty care. Applied in oncology, cardiology, and chronic-disease clinics where depression often accompanies medical illness.
Community and telehealth settings. Short enough to deliver by phone, tablet, or online form.

What does the PHQ-2 measure?

The PHQ-2 measures the two core symptoms used to identify depression in standard diagnostic criteria, asking how often each has bothered the patient over the last two weeks. It does not diagnose depression on its own; it signals whether a more complete evaluation is needed.

Depressed mood. How often the person has felt down, depressed, or hopeless.
Anhedonia. How often the person has had little interest or pleasure in doing things.

Scoring the PHQ-2

Number of items. 2.
Per-item scale. Each item is rated 0 (not at all), 1 (several days), 2 (more than half the days), or 3 (nearly every day).
Total score range. 0 to 6.
Score direction. Higher totals indicate more frequent depressive symptoms.

The PHQ-2 is a screen, not a diagnosis. A commonly used cutoff of 3 or higher indicates a positive screen that warrants further assessment, most often with the PHQ-9 or a clinical interview. Scores should be interpreted alongside history and clinical judgment, and a negative screen does not rule out depression.

Score	Interpretation	Suggested next step
0 to 2	Negative screen; depression less likely	Monitor and re-screen as indicated
3 to 6	Positive screen; possible depression	Consider further assessment with the PHQ-9 or a clinical interview

Best practices for administration

Use the two-week window. Ask patients to answer for how they have felt over the last two weeks.
Screen routinely. Build the PHQ-2 into intake so eligible patients are screened consistently.
Follow up positives. Move a score of 3 or higher to a fuller assessment rather than acting on the screen alone.
Keep the wording standard. Present the validated item wording and response options without editing them.
Protect privacy. Let patients complete the screen in a private setting to encourage honest answers.

How Zentake helps with the PHQ-2

Automatic scoring. Totals are calculated on submit, so there is no hand-tallying.
Before the visit. Mental health practices can have patients complete it from home on any device, so the clinician starts informed.
HIPAA compliant. Data is encrypted, with a signed BAA on every plan.

References

Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: validity of a two-item depression screener. Medical Care. 2003;41(11):1284-1292. This validation study reported that a cutoff of 3 or higher had a sensitivity of 83 percent and a specificity of 92 percent for major depression.

The PHQ screeners, including the PHQ-2, are made available by Pfizer for free public use, with no permission required to reproduce, translate, or distribute them. See the PHQ screener resource for terms.

Last updated: August 2026

Patient Health Questionnaire-2 questions, answered.

What is the PHQ-2 used for?

The PHQ-2 is a two-item questionnaire used to screen for depression. It asks about depressed mood and loss of interest over the past two weeks, giving clinicians a quick first-step check. A positive result signals that a fuller assessment, such as the PHQ-9, may be warranted.

How is the PHQ-2 scored?

Each of the two items is rated from 0 (not at all) to 3 (nearly every day), based on how often the symptom occurred over the last two weeks. The two ratings are added for a total score ranging from 0 to 6, where higher totals mean more frequent symptoms.

What is a positive PHQ-2 score?

A total of 3 or more is the most commonly used cutoff for a positive screen. In the original validation study, this threshold had a sensitivity of 83 percent and a specificity of 92 percent for major depression. A positive screen prompts further evaluation rather than a diagnosis.

What is the difference between the PHQ-2 and the PHQ-9?

The PHQ-2 uses the first two items of the PHQ-9 as a brief initial screen. The PHQ-9 adds seven more items to assess symptom severity and support monitoring over time. Practices often screen with the PHQ-2, then administer the PHQ-9 when the shorter screen is positive.

Can the PHQ-2 diagnose depression?

No. The PHQ-2 is a screening tool, not a diagnostic test. It flags patients who may have depression so clinicians can decide whether to complete a fuller assessment or clinical interview. A negative screen does not rule out depression, so results are interpreted alongside history and judgment.

Is the PHQ-2 free to use?

Yes. The PHQ screeners, including the PHQ-2, are made available by Pfizer for free public use. No permission is required to reproduce, translate, or distribute them, which makes the tool easy to build into routine intake workflows across primary care and behavioral health settings.